Hypomagnesemia risk factors: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
== Overview == | == Overview == | ||
The following patients have high risk of hypoglycemia development, critically ill patients, hospitalized patients, burned patients, head and neck cancer patients treated with cetuximab | |||
== Risk factors == | == Risk factors == | ||
The following patients have high risk of hypoglycemia development: | |||
* Critically ill patients | *Critically ill patients | ||
* | * Hospitalized patients | ||
* | * Burned patients<ref name="pmid15633562">{{cite journal| author=Durán-Vega HC, Romero-Aviña FJ, Gutiérrez-Salgado JE, Silva-Díaz T, Ramos-Durón LE, Carrera-Gómez FJ| title=[Risk factors for development of hypomagnesemia in the burned patient]. | journal=Gac Med Mex | year= 2004 | volume= 140 | issue= 6 | pages= 577-82 | pmid=15633562 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15633562 }}</ref> | ||
*Head and neck cancer patients treated with cetuximab<ref name="pmid27683640">{{cite journal| author=Enokida T, Suzuki S, Wakasugi T, Yamazaki T, Okano S, Tahara M| title=Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab. | journal=Front Oncol | year= 2016 | volume= 6 | issue= | pages= 196 | pmid=27683640 | doi=10.3389/fonc.2016.00196 | pmc=5021713 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27683640 }}</ref> | |||
<br /> | |||
==References== | ==References== | ||
Latest revision as of 17:32, 16 April 2020
|
Hypomagnesemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypomagnesemia risk factors On the Web |
|
American Roentgen Ray Society Images of Hypomagnesemia risk factors |
|
Risk calculators and risk factors for Hypomagnesemia risk factors |
Overview
The following patients have high risk of hypoglycemia development, critically ill patients, hospitalized patients, burned patients, head and neck cancer patients treated with cetuximab
Risk factors
The following patients have high risk of hypoglycemia development:
- Critically ill patients
- Hospitalized patients
- Burned patients[1]
- Head and neck cancer patients treated with cetuximab[2]
References
- ↑ Durán-Vega HC, Romero-Aviña FJ, Gutiérrez-Salgado JE, Silva-Díaz T, Ramos-Durón LE, Carrera-Gómez FJ (2004). "[Risk factors for development of hypomagnesemia in the burned patient]". Gac Med Mex. 140 (6): 577–82. PMID 15633562.
- ↑ Enokida T, Suzuki S, Wakasugi T, Yamazaki T, Okano S, Tahara M (2016). "Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab". Front Oncol. 6: 196. doi:10.3389/fonc.2016.00196. PMC 5021713. PMID 27683640.